Literature DB >> 15111765

Use of complementary and alternative medicine by chinese women with breast cancer.

Yong Cui1, Xiao-Ou Shu, Yutang Gao, Wanqing Wen, Zhi-Xian Ruan, Fan Jin, Wei Zheng.   

Abstract

The use of complementary and alternative medicine (CAM) has been rapidly increasing among cancer patients. The aim of this study is to evaluate the prevalence and patterns of CAM use, particularly patients' intentions and their perceived effectiveness of using Chinese herbal medicine (CHM), as well as the relations between the herbal medicine use and demographic and clinical factors among Chinese women with breast cancer. We analyzed the data from a population-based sample of 1065 breast cancer women in urban Shanghai. Patients' average age at diagnosis was 48.1 years and the median time from the initial diagnosis to the follow-up survey was 4.3 years. Overall, 98% of patients had used at least one form of CAM therapy after diagnosis of breast cancer. The most popular CAM modality was traditional Chinese medicine (86.7%), followed by the use of supplements (84.8%), physical exercises (65.5%), and support group attendance (16.6%). CHM was used by 86.4% of patients, while acupuncture was used only by 4.9% of patients. Treating cancer (81.5%) was the most common intentions of using CHM. Other cited intentions included enhancing the immune system (12%), preventing metastasis of cancer or managing other discomforts (7.9%), and lessening menopausal symptoms (4.7%). The majority of patients reported that they had benefited from the use of CHM. Patients who were younger, married, had higher education or income, received chemotherapy or radiotherapy, or had recurrence/metastasis of cancer tended to use CHM more frequently than other patients. The relations between patient characteristics and use of CHMs varied with users' intentions. Given the high prevalence of CAM use among breast cancer patients, research is urgently needed to systematically evaluate the efficacy and safety of CAM use, particularly use of herbal medicines. Copyright 2004 Kluwer Academic Publishers

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111765     DOI: 10.1023/B:BREA.0000025422.26148.8d

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  71 in total

1.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

2.  The association between fear of cancer recurrence and quality of life among Chinese cancer survivors: main effect hypothesis and buffering hypothesis.

Authors:  Dalnim Cho; Qian Lu
Journal:  Qual Life Res       Date:  2017-04-28       Impact factor: 4.147

3.  Use of complementary and alternative medicine by cancer patients at Zhejiang University Teaching Hospital Zhuji Hospital, China.

Authors:  Lisong Teng; Ketao Jin; Kuifeng He; Chunge Bian; Weili Chen; Kaiyan Fu; Tieming Zhu; Zhigang Jin
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-07-03

4.  A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer.

Authors:  Neora Yaal-Hahoshen; Yair Maimon; Nava Siegelmann-Danieli; Shahar Lev-Ari; Ilan G Ron; Fani Sperber; Noah Samuels; Jacob Shoham; Ofer Merimsky
Journal:  Oncologist       Date:  2011-06-28

5.  Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis.

Authors:  Bahadir M Gulluoglu; Asim Cingi; Tebessum Cakir; Afsar Barlas
Journal:  Breast Care (Basel)       Date:  2008-08-11       Impact factor: 2.860

6.  Reducing postsurgical exudate in breast cancer patients by using San Huang decoction to ameliorate inflammatory status: a prospective clinical trial.

Authors:  Z Y Zhu; J X Xue; L X Yu; W H Bian; Y F Zhang; K C Sohn; I H Shin; C Yao
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

7.  An assessment of the impact of herb-drug combinations used by cancer patients.

Authors:  Saud M Alsanad; Rachel L Howard; Elizabeth M Williamson
Journal:  BMC Complement Altern Med       Date:  2016-10-18       Impact factor: 3.659

Review 8.  The value of acupuncture in cancer care.

Authors:  Weidong Lu; Elizabeth Dean-Clower; Anne Doherty-Gilman; David S Rosenthal
Journal:  Hematol Oncol Clin North Am       Date:  2008-08       Impact factor: 3.722

9.  Use of Chinese herbal medicine therapies in comprehensive hospitals in central China: A parallel survey in cancer patients and clinicians.

Authors:  Gang Chen; Ting-Ting Qiao; Hao Ding; Chen-Xi Li; Hui-Ling Zheng; Xiao-Ling Chen; Shao-Ming Hu; Shi-Ying Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

10.  Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey.

Authors:  Yuen-chi Lam; Chung-wah Cheng; Heng Peng; Chun-key Law; Xianzhang Huang; Zhaoxiang Bian
Journal:  Chin Med       Date:  2009-12-30       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.